Prelude Therapeutics PRLD shares fell 17.4% to $0.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $49.5 million. Stoke Therapeutics STOK shares declined by 11 ...
Invivyd, Inc. (NASDAQ:IVVD – Get Free Report) was the recipient of unusually large options trading on Thursday. Traders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback